Morphine-6-glucuronide
Names | |
---|---|
Other names
M6G
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.161.871 |
MeSH | Morphine-6-glucuronide |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C23H27NO9 | |
Molar mass | 461.46 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Morphine-6-glucuronide (M6G) is a major active metabolite of morphine. M6G is formed from morphine by the enzyme UGT2B7.[1] It has analgesic effects more potent than morphine.[2] M6G can accumulate to toxic levels in kidney failure.[3][4]
History of discovery
This analgesic activity of M6G (in animals) was first noted by Yoshimura.[5]
Subsequent work at
It was postulated that kidney impairment would result in accumulation of the kidney-excreted active agent M6G, leading to potentially fatal toxicity such as respiratory depression. The frequent use of morphine in critically ill patients, and the common occurrence of kidney failure in this group implied that M6G accumulation could be a common, but previously unanticipated problem. The first studies demonstrated massive levels of M6G in 3 patients with kidney failure, which resolved as kidney function returned.[3] Accumulation of M3G and M6G also decreased with return of kidney function after kidney transplantation.[4]
A key step in defining the importance of M6G in humans came in 1992 when the substance was artificially synthesised and administered to patients with pain, the majority of whom described pain relief.[9]
See also
References
- PMID 9010622.
- S2CID 18890026.
- ^ PMID 3087512.
- ^ S2CID 44954994.
- PMID 5778147.
- S2CID 37751253.
- PMID 3235512.
- ^ Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. JT Van Crugten, BC Sallustio, RL Nation and AA Somogyi. Department of Clinical and Experimental Pharmacology, University of Adelaide, Australia.
- PMID 1419474.